Alector Inc
(NAS:ALEC)
$
5.44
-0.05 (-0.91%)
Market Cap: 524.33 Mil
Enterprise Value: -194,000.00
PE Ratio: 0
PB Ratio: 2.93
GF Score: 68/100 Alector Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021 / 07:25PM GMT
Release Date Price:
$19.05
(+8.86%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
Okay. Good afternoon, and welcome to day 3 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays, and welcome. We are pleased to welcome Alector to next up for a virtual fireside chat. Representing the company is President and COO, Shehnaaz Suliman. Shehnaaz, welcome very much.
Shehnaaz Suliman
Alector, Inc. - President , COO & Interim Chief Business Officer
Thank you, Carter. It's a pleasure to be here.
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
I believe you're going to make some opening comments, and then we'll hop into Q&A.
Shehnaaz Suliman
Alector, Inc. - President , COO & Interim Chief Business Officer
Absolutely, I'll be delighted to do that. So we, at Alector, have been pioneering immuno-neurology since Arnon Rosenthal founded and CEOs started the company about 8 years ago. And what that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot